Susquehanna International Group
CASI

Susquehanna International Group’s CASI Pharmaceuticals CASI Stock Holding History

Susquehanna International Group’s Portfolio CASI Stock Details CASI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-10,151
Closed -$12K – 12495
2025
Q2 		$12K Sell
10,151
-10,992
-52% -$20.1K ﹤0.01% 12392
2025
Q1 		$45.7K Buy
+21,143
New +$51.7K ﹤0.01% 11895
2023
Q2 		– Sell
-38,326
Closed -$88.2K – 12126
2023
Q1 		$88.2K Sell
38,326
-19,069
-33% -$36.7K ﹤0.01% 11384
2022
Q4 		$100K Buy
57,395
+23,758
+71% +$47.1K ﹤0.01% 10956
2022
Q3 		$87K Buy
+33,637
New +$108K ﹤0.01% 11807
2022
Q2 		– Sell
-38,927
Closed -$315K – 12953
2022
Q1 		$315K Sell
38,927
-14,179
-27% -$111K ﹤0.01% 10152
2021
Q4 		$425K Buy
53,106
+29,895
+129% +$298K ﹤0.01% 9595
2021
Q3 		$276K Buy
+23,211
New +$314K ﹤0.01% 10778
2021
Q2 		– Sell
-2,740
Closed -$66K – 12587
2021
Q1 		$66K Buy
2,740
+1,411
+106% +$39.6K ﹤0.01% 11980
2020
Q4 		$39K Sell
1,329
-1,338
-50% -$29.1K ﹤0.01% 10802
2020
Q3 		$41K Buy
+2,667
New +$50.2K ﹤0.01% 10252
2020
Q2 		– Sell
-1,422
Closed -$29K – 10164
2020
Q1 		$29K Buy
+1,422
New +$33.9K ﹤0.01% 9833
2019
Q4 		– Sell
-2,240
Closed -$75K – 9752
2019
Q3 		$75K Sell
2,240
-282
-11% -$9.05K ﹤0.01% 9668
2019
Q2 		$81K Buy
+2,522
New +$80.5K ﹤0.01% 9692
2018
Q3 		– Sell
-1,019
Closed -$84K – 9256
2018
Q2 		$84K Sell
1,019
-13,049
-93% -$881K ﹤0.01% 9105
2018
Q1 		$587K Buy
14,068
+11,614
+473% +$434K ﹤0.01% 6298
2017
Q4 		$80K Buy
+2,454
New +$66.7K ﹤0.01% 8773
2017
Q3 		– Sell
-1,785
Closed -$19K – 8839
2017
Q2 		$19K Buy
+1,785
New +$19K ﹤0.01% 9026
2016
Q1 		– Sell
-1,351
Closed -$13K – 9029
2015
Q4 		$13K Buy
+1,351
New +$15.3K ﹤0.01% 9269

Other funds holding CASI

VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
FCMV
Foresite Capital Management VI Larkspur, California $460M AUM 261.77% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
WSCM
Wellington Shields Capital Management New York $666M AUM 45.43% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
WSC
Wellington Shields & Co New York $392M AUM 30.65% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
GSC
Ground Swell Capital Folly Beach, South Carolina $50.7M AUM 30.19% 1-Year Est. Return

Susquehanna International Group's CASI Position: Q3 2025 in Review

Susquehanna International Group sold out of CASI Pharmaceuticals (CASI) in Q3 2025, closing a stake of 10,151 shares — an estimated $12K sold.

Susquehanna International Group first reported a position in CASI in Q4 2015 and held it in 19 quarters. The position peaked at $587K in Q1 2018. 22 funds tracked by Wall St. Rank hold CASI as of Q3 2025.

  • Susquehanna International Group reported no remaining CASI Pharmaceuticals position as of Q3 2025 after selling out during the quarter.
  • Susquehanna International Group sold 10,151 CASI Pharmaceuticals shares in Q3 2025, an estimated $12K.
  • Susquehanna International Group first reported a position in CASI Pharmaceuticals in Q4 2015 and held it in 19 quarters.
  • Susquehanna International Group's CASI Pharmaceuticals position peaked at $587K in Q1 2018.
  • 22 funds tracked by Wall St. Rank held CASI Pharmaceuticals as of Q3 2025.

Based on Susquehanna International Group's 13F filing for Q3 2025, filed 14 Nov 2025.